149 related articles for article (PubMed ID: 1870150)
1. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine.
Johnston D; Bystryn JC
J Natl Cancer Inst; 1991 Sep; 83(17):1240-5. PubMed ID: 1870150
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.
Ravindranath MH; Brazeau SM; Morton DL
Experientia; 1994 Jul; 50(7):648-53. PubMed ID: 8033972
[TBL] [Abstract][Full Text] [Related]
3. Effect of DETOX as an adjuvant for melanoma vaccine.
Schultz N; Oratz R; Chen D; Zeleniuch-Jacquotte A; Abeles G; Bystryn JC
Vaccine; 1995 Apr; 13(5):503-8. PubMed ID: 7639018
[TBL] [Abstract][Full Text] [Related]
4. Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A.
Vitoriano-Souza J; Moreira Nd; Teixeira-Carvalho A; Carneiro CM; Siqueira FA; Vieira PM; Giunchetti RC; Moura SA; Fujiwara RT; Melo MN; Reis AB
PLoS One; 2012; 7(7):e40745. PubMed ID: 22829882
[TBL] [Abstract][Full Text] [Related]
5. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice.
Chodaczek G; Zimecki M; Lukasiewicz J; Lugowski C
Med Microbiol Immunol; 2006 Dec; 195(4):207-16. PubMed ID: 16838169
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
7. Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity.
Baldridge JR; Ward JR
Vaccine; 1997 Mar; 15(4):395-401. PubMed ID: 9141210
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.
Baral R; Mandal I; Chattopadhyay U
Int Immunopharmacol; 2005 Jul; 5(7-8):1343-52. PubMed ID: 15914339
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
[TBL] [Abstract][Full Text] [Related]
11. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.
Hovav AH; Fishman Y; Bercovier H
Infect Immun; 2005 Jan; 73(1):250-7. PubMed ID: 15618161
[TBL] [Abstract][Full Text] [Related]
12. Effects of the adjuvant MPL + TDM on tumor challenge in the B16 mouse melanoma model.
Price JA; McGee JM; Patten MR; Snyder D
Int J Immunopharmacol; 1996 Feb; 18(2):163-5. PubMed ID: 8799366
[TBL] [Abstract][Full Text] [Related]
13. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
Chaitra MG; Nayak R; Shaila MS
Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
[TBL] [Abstract][Full Text] [Related]
14. Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
Vitoriano-Souza J; Siqueira Mathias FA; Moreira NDD; Aguiar-Soares RDO; de Abreu Vieira PM; Teixeira-Carvalho A; Carneiro CM; Giunchetti RC; de Brito RCF; Fujiwara RT; Roatt BM; Melo MN; Reis AB
Vaccine; 2019 Nov; 37(49):7269-7279. PubMed ID: 31575491
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
16. Dissociated induction of cytotoxicity and DTH by CFA and CpG.
Tigno-Aranjuez JT; Lehmann PV; Tary-Lehmann M
J Immunother; 2009 May; 32(4):389-98. PubMed ID: 19342966
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.
Wang YQ; Zhang HH; Liu CL; Wu H; Wang P; Xia Q; Zhang LX; Li B; Wu JX; Yu B; Gu TJ; Yu XH; Kong W
Int Immunopharmacol; 2013 Sep; 17(1):9-17. PubMed ID: 23624214
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.
Rawlings DJ; Kaslow DC
J Exp Med; 1992 Nov; 176(5):1483-7. PubMed ID: 1383389
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
[TBL] [Abstract][Full Text] [Related]
20. Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12.
Staib L; Harel W; Mitchell MS
Melanoma Res; 2001 Aug; 11(4):325-35. PubMed ID: 11479420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
